Von Recklinghausen's disease, neurofibromatosis type 1 (NF1), is a commonautosomal disorder characterized by multiple neurofibromas, cafe au lait spots, and Lisch nodules of the iris with a variable clinical expression. This disorder appears to affect all races, with a prevalence estimated to be 1 in 3,000 live births. The NF1 gene is located in 17ql 1.2. However, due to the high mutation rate at the NF1locus, most patients are expected to have different mutations (1) (2) (3) . Lung involvement in NF1 is a well-known complication, and it consists of diffuse interstitial fibrosis and bullae, either alone or in combination. The interstitial fibrosis characteristically involves both lungs symmetrically with some basal predominance, whereas the bullae usually are asymmetric and tend to develop in the upper lobes (4). However, histological examination has revealed that the fibrosis is seen in all patients with bullae. Estimated incidences of interstitial fibrosis have ranged from 7 to 10 percent (5, 6) . Even though the NF1 gene has already been discovered, it is not clear whether the NF1 locus is also responsible for the lung involvement. In this issue, a 48-year-old manwith NF1 (von Recklinghausen' s disease) whopresented with distal acinar emphysema and interstitial pneumonia is reported ( 7 ) .
See also p 413.
Distal acinar emphysemais recognized as one of the three subcategories of emphysema (8): centriacinar, panacinar and distal acinar. It is usually focal and consists of small emphysematousspaces in a more or less continuous zone of variable length located in the periphery of the lung adjacent to the pleura or along interlobular septa. Since distal acinal emphysema, in contrast to the other types, is generally thought to be not closely related to smoking history, coexistence of this type of emphysemaand fibrosis in the patient leads to the speculation that distal acinar emphysema maybe a unique manifestation of smoking-induced lung injury in a case ofNF1. The authors in this paper also reported that smokingcessation suppressed the decline of pulmonary function during the 5-year follow-up period. This beneficial effect of smoking cessation seen in this patient suggests someconnection of distal acinal emphysemaand smoking in this particular case. These findings may indicate that the repair process for smoking-induced lung injury is somehowgenetically determined. It remains to be seen how the effect of smoking on lung injury involvement appear in acase ofNF1.
It is important to note that pulmonary manifestation in cases of NF1seems to be a mixture of interstitial fibrosis and emphysema. The two disorders are generally considered to be separate. Each has distinguished clinical, radiological, physiological and pathological characteristics. Both disorders are at some stage associated with inflammation. Manyresearchers have focused on the inflammatory process in the formation of both emphysemaand fibrosis, such as protease, and oxygen radicals. There has been another view that they simply represent different manifestations in response to the same lung injury. Niewoehner and Hoidal (9), indeed, demonstrated that cadmiumchloride, administered intratracheally to golden hamsters, causes an acute lung injury which develops into diffuse fibrosis. However, with simultaneous feeding of a lathyroge, beta-aminopfoprionitrile, this cadmiumchloride-induced lung injury evolves into bullous emphysema. They concluded the same lung injury might result in either fibrosis or emphysema, during the healing phase being the critical determinant. If this hypothesis is true in the lung involvement in NF1, the healing process might be somehowgenetically determined.
If the repair process to some lung injury is genetically determined, the lung involvement in NF1 would serve as a good model where one can investigate the mechanismsbehind such a variable repair process for smoking-induced lung injury.
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